4-Chloromethyl-2-(4-methoxy-phenyl)-5-methyl-thiazole, 95.0%, 1g

(R)-1-(p-Tolyl)ethanamine, 95.0%, 5g

(1H-Pyrrolo[2,3-b]pyridin-5-yl)methanamine, 95.0%, 250mg

7-BOC-2,7-DIAZABICYCLO[4.2.0]OCTANE, 95.0%, 1g

Methyl 2-(1,3-dioxo-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-4-yl)acetate, 97%, 500mg

(S)-4-N-Boc-Piperazine-2-carboxylic acid, 97.0%, 10g

Timidina, mínimo 99 %, pa, 1 g, envase de vidrio

2-(4-Bromopyrazol-1-yl)ethanol, 95.0%, 10g

Methyl 4-(((2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methyl)amino)-2-methoxybenzoate, 97.0%, 1g

ethyl 2-(naphthalen-1-yl)ethanecarboximidate hydrochloride, 95.0%, 2g

1-(4-FLUOROPHENYL)-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXYLIC ACID, 95.0%, 5g

3-Methylcrotonic Acid>98.0%(GC)(T)100g

(R)-tert-Butyl 1-(cyclohexylmethyl)pyrrolidin-3-ylcarbamate, 95.0%, 1g